Skip to main content
SupplementScience

Benefits of Melatonin

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Sleep onset — a 2013 meta-analysis of 19 RCTs (Ferracioli-Oda et al.) found melatonin supplementation significantly reduced sleep onset latency by a weighted mean of 7.06 minutes compared to placebo, with improvements in total sleep time and sleep quality
  • Sleep quality — melatonin improved subjective sleep quality scores across studies, with benefits most pronounced in primary sleep disorders and delayed sleep-wake phase disorder
  • Jet lag treatment — a 2002 Cochrane systematic review (Herxheimer & Petrie) of 10 trials found melatonin remarkably effective for preventing or reducing jet lag, particularly when crossing 5 or more time zones and traveling eastward
  • Circadian rhythm resetting — melatonin acts as a chronobiotic, shifting the phase of the circadian clock, making it the treatment of choice for delayed sleep-wake phase disorder and shift work sleep difficulties
  • Antioxidant effects — melatonin is a potent direct free radical scavenger and also stimulates antioxidant enzymes (superoxide dismutase, glutathione peroxidase), providing neuroprotective effects beyond sleep

What the Research Says

Melatonin is one of the most extensively studied sleep supplements. Ferracioli-Oda et al. (2013) published a pivotal meta-analysis of 19 RCTs involving 1,683 subjects, demonstrating that melatonin significantly reduces sleep onset latency (weighted mean difference -7.06 min), increases total sleep time (+8.25 min), and improves overall sleep quality. Herxheimer & Petrie (2002) conducted a Cochrane review of 10 trials confirming melatonin's efficacy for jet lag prevention and treatment. Brzezinski et al. (2005) meta-analyzed 17 studies confirming melatonin's sleep-promoting effects and noted that efficacy did not diminish with continued use over weeks. A key finding across the literature is the absence of a clear dose-response relationship — Zhdanova et al. (2001) demonstrated that physiological doses (0.3mg) were as effective as pharmacological doses (3mg) for improving sleep in older adults with insomnia.

References

  1. (). Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS ONE. DOI
  2. (). Melatonin for the prevention and treatment of jet lag. Cochrane Database of Systematic Reviews. DOI
  3. (). Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Medicine Reviews. DOI
  4. (). Melatonin treatment for age-related insomnia. Journal of Clinical Endocrinology & Metabolism. DOI